MedTrace Logo

ALFAsleep: Exploring Cognitive and Biological Correlates of Sleep Quality and Their Potential Links With Alzheimer's Disease

NCT04932473 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 179

Last updated 2025-05-31

No results posted yet for this study

Summary

The main goal of this study is to perform a multimodal characterization of brain structural and functional changes, as well as changes in Alzheimer's disease (AD) biomarkers, as a function of sleep quality measures. Cross-sectional data will enable us to confirm and expand previous knowledge in a large and well-phenotyped population, while longitudinal data will allow us to test the hypothesis of the existence of a bidirectional relationship between sleep quality and AD.

Conditions

  • Cognitively Unimpaied

Sponsors & Collaborators

  • Barcelonabeta Brain Research Center, Pasqual Maragall Foundation

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-26
Primary Completion
2022-09-20
Completion
2025-05-27

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04932473 on ClinicalTrials.gov